← Leaderboards
Michael Sean Kent
Omniox, Inc.
$648,464
Attributed
$2,164,381
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $546.8K · FY2019–24$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,164,381 · 2
By mechanism
T32$1,616,911 · 1
R01$547,470 · 1
Top collaborators
- Robert J. Canter5 shared
- Xinbin Chen5 shared
- Simon R Cherry2 shared
- Ana Krtolica2 shared
- Jonathan A Winger2 shared
- Allison Zwingenberger2 shared
Most similar at Omniox, Inc.
Same institution · by research overlap
- Ajit S Shah$6,420,002
- Ana Krtolica$1,680,034
- Allison Zwingenberger$505,594
- Jonathan A Winger$3,362,152
- Stephen Cary$1,668,893
Others in their field
Other Emerging Leaders on “Training Programs”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$73,910,854
- Martha Hering · Westat, Inc.$57,098,843
- Julie Brisset · The University Of Central Florida Board Of Trustees$41,275,036
- Steven A. Ackerman · University Of Wisconsin-Madison$38,898,438
- Timothy M Willson · University Of Cape Town$32,741,597
- Leonard Freedman · Leidos Biomedical Research, Inc.$31,000,000
Research focus
Training ProgramsOncologyComparativeAnimalsBiochemicalBiological MarkersAdjuvantBiomarker PerformanceAffinityBrainBrain ImagingBrain NeoplasmsCaliforniaCancer ImagingCandidate MarkerCancer PatientCanis FamiliarisCarrier ProteinsBlood VesselsBindingCherry - DietaryClinically RelevantClinically TranslatableBiological Sciences
Grant awards (7)
UC Davis Comparative Oncology Training Program$124,734
T32 · FY2024 · CA
UC Davis Comparative Oncology Training Program$290,518
T32 · FY2023 · CA
UC Davis Comparative Oncology Training Program$429,080
T32 · FY2022 · CA
UC Davis Comparative Oncology Training Program$434,033
T32 · FY2021 · CA
UC Davis Comparative Oncology Training Program$338,546
T32 · FY2020 · CA
Development of PET imaging biomarkers to predict enhanced glioblastoma radiotherapy by a novel H-NOX oxygen carrier$704
R01 · FY2020 · CA
Development of PET imaging biomarkers to predict enhanced glioblastoma radiotherapy by a novel H-NOX oxygen carrier$546,766
R01 · FY2019 · CA